GT201500124A - Forma sòlida de un derivado de dihidro-pirido-oxazina - Google Patents

Forma sòlida de un derivado de dihidro-pirido-oxazina

Info

Publication number
GT201500124A
GT201500124A GT201500124A GT201500124A GT201500124A GT 201500124 A GT201500124 A GT 201500124A GT 201500124 A GT201500124 A GT 201500124A GT 201500124 A GT201500124 A GT 201500124A GT 201500124 A GT201500124 A GT 201500124A
Authority
GT
Guatemala
Prior art keywords
pirido
dihidro
oxazina
derivative
solid form
Prior art date
Application number
GT201500124A
Other languages
English (en)
Inventor
Hurth Konstanze
Kalis Christoph
Kammertoens Karen
Soldermann Nicolas
Zecri Frèderic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51019963&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201500124(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201500124A publication Critical patent/GT201500124A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCIÓN SE REFIERE A UNA FORMA CRISTALINA ANHIDRA DE (1,1-DIOXO-HEXAHIDRO-1LAMBDA * 6 * - TIOPIRAN-4-IL) - {(S) -3- [1- (6-METOXI-5-METIL-PIRIDIN -3-IL) -2,3-DIHIDRO-1H-PIRIDO [3,4-B] [1,4] OXAZIN-7-ILOXI] PIRROLIDIN-1-IL} -METANONA; COMPOSICIONES FARMACÉUTICAS Y COMBINACIONES QUE INCLUYEN ESTAS FORMAS, ASÍ COMO A MÉTODOS DE UTILIZACIÓN DE ESTAS FORMAS, INCLUYENDO SUS COMPOSICIONES FARMACÉUTICAS Y COMBINACIONES PARA EL TRATAMIENTO DE ENFERMEDADES.
GT201500124A 2012-11-26 2015-05-26 Forma sòlida de un derivado de dihidro-pirido-oxazina GT201500124A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GC201222895 2012-11-26
IR1391307213 2012-12-04

Publications (1)

Publication Number Publication Date
GT201500124A true GT201500124A (es) 2016-03-01

Family

ID=51019963

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201500124A GT201500124A (es) 2012-11-26 2015-05-26 Forma sòlida de un derivado de dihidro-pirido-oxazina

Country Status (23)

Country Link
EP (1) EP2928896B1 (es)
KR (1) KR102184069B1 (es)
CN (1) CN104870451B (es)
AU (1) AU2013368997B8 (es)
BR (1) BR112015009870A2 (es)
CA (1) CA2891521A1 (es)
CL (1) CL2015001409A1 (es)
CY (1) CY1119702T1 (es)
DK (1) DK2928896T3 (es)
GT (1) GT201500124A (es)
HK (1) HK1209419A1 (es)
IL (1) IL238889B (es)
MX (1) MX366342B (es)
NZ (1) NZ706865A (es)
PE (1) PE20150946A1 (es)
PH (1) PH12015501052A1 (es)
PL (1) PL2928896T3 (es)
PT (1) PT2928896T (es)
SG (1) SG11201503410VA (es)
TN (1) TN2015000128A1 (es)
TW (1) TW201422625A (es)
WO (1) WO2014102630A1 (es)
ZA (1) ZA201502350B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101656592B1 (ko) 2011-12-22 2016-09-23 노파르티스 아게 디히드로-벤조-옥사진 및 디히드로-피리도-옥사진 유도체
AU2019322538B2 (en) 2018-08-13 2021-09-30 F. Hoffmann-La Roche Ag New heterocyclic compounds as monoacylglycerol lipase inhibitors
KR20220062515A (ko) 2019-09-12 2022-05-17 에프. 호프만-라 로슈 아게 Magl 억제제로서 4,4a,5,7,8,8a-헥사피리도[4,3-b][1,4]옥사진-3-온 화합물

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU11248A1 (ru) 1927-03-29 1929-09-30 В.С. Григорьев Способ очистки антрацена
GB1524747A (en) 1976-05-11 1978-09-13 Ici Ltd Polypeptide
LU88769I2 (fr) 1982-07-23 1996-11-05 Zeneca Ltd Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
GB8327256D0 (en) 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US5093330A (en) 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
US5010099A (en) 1989-08-11 1991-04-23 Harbor Branch Oceanographic Institution, Inc. Discodermolide compounds, compositions containing same and method of preparation and use
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
GB9300059D0 (en) 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
TW225528B (es) 1992-04-03 1994-06-21 Ciba Geigy Ag
GB9314893D0 (en) 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
CA2216796C (en) 1995-03-30 2003-09-02 Pfizer Inc. Quinazoline derivatives
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US5747498A (en) 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US5843901A (en) 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
CA2224435C (en) 1995-07-06 2008-08-05 Novartis Ag Pyrrolopyrimidines and processes for the preparation thereof
US5760041A (en) 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
CA2249446C (en) 1996-04-12 2008-06-17 Warner-Lambert Company Irreversible inhibitors of tyrosine kinases
DE69734513T2 (de) 1996-06-24 2006-07-27 Pfizer Inc. Phenylamino-substituierte tricyclische derivate zur behandlung hyperproliferativer krankheiten
WO1998008849A1 (de) 1996-08-30 1998-03-05 Novartis Aktiengesellschaft Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens
CA2264908C (en) 1996-09-06 2006-04-25 Obducat Ab Method for anisotropic etching of structures in conducting materials
AU4342997A (en) 1996-09-13 1998-04-02 Sugen, Inc. Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders
EP0837063A1 (en) 1996-10-17 1998-04-22 Pfizer Inc. 4-Aminoquinazoline derivatives
WO1998022461A1 (de) 1996-11-18 1998-05-28 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Epothilone c, d, e und f, deren herstellung und deren verwendung als cytostatische mittel bzw. als pflanzenschutzmittel
US6441186B1 (en) 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
IL138113A0 (en) 1998-02-25 2001-10-31 Sloan Kettering Inst Cancer Synthesis of epothilones, intermediates thereto and analogues thereof
PT1107964E (pt) 1998-08-11 2010-06-11 Novartis Ag Derivados de isoquinolina com actividade inibidora da angiogénese
CA2350189A1 (en) 1998-11-20 2000-06-02 Kosan Biosciences, Inc. Recombinant methods and materials for producing epothilone and epothilone derivatives
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
NZ525656A (en) 2000-11-07 2004-12-24 Novartis Ag Indolylmaleimide derivatives as protein kinase C inhibitors
TWI238824B (en) 2001-05-14 2005-09-01 Novartis Ag 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
GB0119249D0 (en) 2001-08-07 2001-10-03 Novartis Ag Organic compounds
TWI324064B (en) 2002-04-03 2010-05-01 Novartis Ag Indolylmaleimide derivatives
KR20050084224A (ko) 2002-12-09 2005-08-26 더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 야누스 티로신 키나제 3을 선택적으로 저해하는 방법
EP1704145B1 (en) 2004-01-12 2012-06-13 YM BioSciences Australia Pty Ltd Selective kinase inhibitors
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
CN101300047A (zh) * 2005-09-07 2008-11-05 雪兰诺实验室有限公司 Pi3k抑制剂用于子宫内膜异位症的治疗
GB0620059D0 (en) * 2006-10-10 2006-11-22 Ucb Sa Therapeutic agents
KR101656592B1 (ko) * 2011-12-22 2016-09-23 노파르티스 아게 디히드로-벤조-옥사진 및 디히드로-피리도-옥사진 유도체

Also Published As

Publication number Publication date
EP2928896A1 (en) 2015-10-14
NZ706865A (en) 2016-04-29
TN2015000128A1 (en) 2016-10-03
AU2013368997B8 (en) 2015-10-08
CA2891521A1 (en) 2014-07-03
AU2013368997B2 (en) 2015-09-24
PL2928896T3 (pl) 2018-01-31
CY1119702T1 (el) 2018-06-27
AU2013368997A1 (en) 2015-04-30
TW201422625A (zh) 2014-06-16
KR20150091047A (ko) 2015-08-07
PE20150946A1 (es) 2015-06-28
CN104870451A (zh) 2015-08-26
CN104870451B (zh) 2017-07-07
IL238889A0 (en) 2015-07-30
CL2015001409A1 (es) 2015-07-24
PT2928896T (pt) 2017-10-25
SG11201503410VA (en) 2015-05-28
KR102184069B1 (ko) 2020-11-30
MX366342B (es) 2019-07-05
EP2928896B1 (en) 2017-07-19
IL238889B (en) 2021-03-25
AU2013368997A8 (en) 2015-10-08
DK2928896T3 (da) 2017-11-06
PH12015501052A1 (en) 2015-07-27
WO2014102630A1 (en) 2014-07-03
ZA201502350B (en) 2017-08-30
HK1209419A1 (en) 2016-04-01
BR112015009870A2 (pt) 2017-12-05
MX2015006650A (es) 2015-08-10

Similar Documents

Publication Publication Date Title
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
CR20150370A (es) Compuestos antivirales
NI201600071A (es) Compuestos de inhibidor de autotaxina
GT201400063A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
DOP2012000257A (es) Derivados del acido 1-amino-2-ciclopropiletilboronico
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
GT201400162A (es) Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas
UY35210A (es) Inhibidores de autotaxina
CL2015000543A1 (es) Derivados de alcanediil y alcanediil-c17, de ácido oleanólico compuestos intermediarios, composición parmacéutica y métodos asociados.
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
CU20140048A7 (es) Novedosos derivados de purina útiles en el tratamiento del cáncer y trastornos neurodegenerativos
GT201400111A (es) Triazolopiridinas sustituidas
UY33353A (es) Compuestos adecuados para el tratamiento de trastornos metabolicos y metodos de preparacion
PE20150631A1 (es) Formas cristalinas de un modulador del receptor androgenico
UY34648A (es) Amidas como inhibidores de pim
CO6781507A2 (es) Novedosos derivados heterociclicos
UY33943A (es) Derivados espirocíclicos de isoxazolina como agentes antiparasitarios.
AR089993A1 (es) Macrociclos peptidomimeticos
UY33735A (es) Compuestos antivirales
UY34165A (es) ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?.
GT201300258A (es) Derivados de pirazoloespirocetona para uso como inhibidores de acetil-coa carboxilasa
CR20140553A (es) Compuestos de fenoxietil piperidina
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
UY34615A (es) Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias.